糖皮质激素联合利妥昔单抗治疗难治性皮肤结节性多动脉炎1例成功

IF 0.2 Q4 DERMATOLOGY
Ibrahim A. Al-Homood, Mohammad A. Aljahlan
{"title":"糖皮质激素联合利妥昔单抗治疗难治性皮肤结节性多动脉炎1例成功","authors":"Ibrahim A. Al-Homood,&nbsp;Mohammad A. Aljahlan","doi":"10.1016/j.jdds.2016.05.004","DOIUrl":null,"url":null,"abstract":"<div><p>Cutaneous polyarteritis nodosa is a rare subtype of polyarteritis nodosa that lacks significant internal organ involvement. It has a relapsing remitting nature and usually is less responsive to conventional treatments. We report a case of refractory cutaneous polyarteritis nodosa who failed three immunosuppressive therapies and three different biological agents. He was successfully treated with two rituximab 1000<!--> <!-->mg infusions with a good efficacy and tolerance. This case demonstrates the safety and efficacy of rituximab in treatment of refractory cutaneous polyarteritis nodosa.</p></div>","PeriodicalId":43409,"journal":{"name":"Journal of Dermatology & Dermatologic Surgery-JDDS","volume":"21 1","pages":"Pages 24-26"},"PeriodicalIF":0.2000,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.jdds.2016.05.004","citationCount":"4","resultStr":"{\"title\":\"Successful use of combined corticosteroids and rituximab in a patient with refractory cutaneous polyarteritis nodosa\",\"authors\":\"Ibrahim A. Al-Homood,&nbsp;Mohammad A. Aljahlan\",\"doi\":\"10.1016/j.jdds.2016.05.004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Cutaneous polyarteritis nodosa is a rare subtype of polyarteritis nodosa that lacks significant internal organ involvement. It has a relapsing remitting nature and usually is less responsive to conventional treatments. We report a case of refractory cutaneous polyarteritis nodosa who failed three immunosuppressive therapies and three different biological agents. He was successfully treated with two rituximab 1000<!--> <!-->mg infusions with a good efficacy and tolerance. This case demonstrates the safety and efficacy of rituximab in treatment of refractory cutaneous polyarteritis nodosa.</p></div>\",\"PeriodicalId\":43409,\"journal\":{\"name\":\"Journal of Dermatology & Dermatologic Surgery-JDDS\",\"volume\":\"21 1\",\"pages\":\"Pages 24-26\"},\"PeriodicalIF\":0.2000,\"publicationDate\":\"2017-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.jdds.2016.05.004\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Dermatology & Dermatologic Surgery-JDDS\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S235224101630007X\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"DERMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Dermatology & Dermatologic Surgery-JDDS","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S235224101630007X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 4

摘要

皮肤结节性多动脉炎是一种罕见的结节性多动脉炎亚型,缺乏明显的内脏受累。它具有复发缓解的性质,通常对常规治疗反应较小。我们报告一例难治性皮肤结节性多动脉炎,三种免疫抑制治疗和三种不同的生物制剂均无效。2次输注利妥昔单抗1000 mg治疗成功,疗效好,耐受性好。本病例证明了利妥昔单抗治疗难治性皮肤结节性多动脉炎的安全性和有效性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Successful use of combined corticosteroids and rituximab in a patient with refractory cutaneous polyarteritis nodosa

Cutaneous polyarteritis nodosa is a rare subtype of polyarteritis nodosa that lacks significant internal organ involvement. It has a relapsing remitting nature and usually is less responsive to conventional treatments. We report a case of refractory cutaneous polyarteritis nodosa who failed three immunosuppressive therapies and three different biological agents. He was successfully treated with two rituximab 1000 mg infusions with a good efficacy and tolerance. This case demonstrates the safety and efficacy of rituximab in treatment of refractory cutaneous polyarteritis nodosa.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
17
审稿时长
16 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信